StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Valeant Pharma (VRX) Plunges as Philidor Practices Questioned, PBMs Cut Ties
October 29, 2015 5:19 PM
After staging an impressive recovery off last week's lows, Valeant Pharma (NYSE: VRX) is back in the cross-hairs and testing ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Short Sales
Trader Talk
Next Articles
Margin Pressures Could Weigh on CVS Health (CVS) Shares; Oppenheimer Cuts Price Target to $115
November 2, 2015 11:16 AM
Leerink Partners Would Buy CVS Health (CVS) on Current Weakness
October 30, 2015 1:39 PM
Evercore ISI's Raffat Provides Thoughts on Valeant Pharma (VRX)
October 30, 2015 8:14 AM
Valeant Pharma (VRX) to Sever Ties with Philidor
October 30, 2015 5:59 AM
UPDATE: Philidor said to Modify Prescriptions to Boost Valeant (VRX) Sales
October 29, 2015 4:49 PM
Express Scripts (ESRX) terminating Philidor pharmacy from its network - Bloomberg (VRX)
October 29, 2015 4:41 PM
CVS Health (CVS) Comments on Philidor Relationship (VRX)
October 29, 2015 4:00 PM
